Financial Data and Key Metrics Changes - In Q4 2024, NeueHealth reported consolidated revenue of $232.6 million, with full-year revenue reaching $936.7 million [15] - The gross margin for Q4 was $47.7 million, while the full-year gross margin was $194.5 million [15] - Adjusted EBITDA for Q4 was $5.5 million, contributing to a total of $22.5 million for the full year, marking the fourth consecutive quarter of adjusted EBITDA profitability [15] Business Line Data and Key Metrics Changes - In the NeueCare segment, Q4 revenue was $79.3 million, with full-year revenue at $313.7 million; operating income for Q4 was $9.2 million and $29.6 million for the full year [16] - The NeueSolutions segment generated $157.1 million in revenue for Q4 and $635.1 million for the full year, with an operating income of $3.1 million for Q4 and an operating loss of $5.3 million for the full year [18] Market Data and Key Metrics Changes - NeueHealth served 483,000 consumers in 2024, reflecting a compound annual growth rate of 123% since 2020; this number increased to 717,000 consumers at the start of 2025, a 31% growth from 2024 [10][11] - The company expanded its consumer base in recently expanded markets by 97% [11] Company Strategy and Development Direction - NeueHealth aims to continue its focus on high-quality, affordable healthcare, diversifying the populations served across product categories [24] - The company plans to deepen its presence in local communities and expand into new geographies, enhancing its care model [24] - There is a commitment to grow alongside payer partners and strengthen relationships with providers to enable high-quality personalized care [25] Management's Comments on Operating Environment and Future Outlook - Management expressed confidence in the company's ability to drive change in the healthcare industry and create a seamless experience for consumers, providers, and payers [26] - The company anticipates closing a transaction to be acquired by an affiliate of NEA in Q2 2025, which is expected to provide flexibility and resources for continued growth [12][13] Other Important Information - As of December 31, 2024, NeueHealth had $202.8 million in total cash and investments, with $93.2 million in nonregulated cash and short-term investments [20] Q&A Session Summary - No specific questions and answers were provided in the content.